Unilabs appoints Victoria Bell as Group Chief Financial Officer

Geneva, 11 November 2020: Unilabs, the leading European diagnostic services provider, has appointed Victoria Bell as Group Chief Financial Officer ad interim. Victoria will report to Michiel Boehmer, Unilabs’ President and COO, and be part of the Unilabs Management Team. She replaces Andrew Derodra, who has decided to leave Unilabs for personal reasons.  

Andrew remains on board until 1 December to oversee the transition and ensure an orderly handover. 

“We respect Andrew’s decision and thank him for his contributions to Unilabs over the past years. At the same time, we’re delighted to welcome Victoria to the team,” said Michiel Boehmer. “She will play a fundamental part in delivering our strategic objectives, supporting the growth of our business, and delivering long-term value.”

Before joining Unilabs, Victoria Bell served as Interim Finance Transformation Director at the Kantar Group in London.

She has extensive international experience in senior roles in companies including Centrient Pharmaceuticals, Wittur Group, J.P. Morgan, and Société Générale.                     

Victoria is a British citizen. She is a Chartered Accountant and holds a Bachelor of Laws with Honours.

Media contact:

Alistair Hammond, Director of Communications

e: Alistair.Hammond@unilabs.com

t: +44 771 773 0441

About Unilabs

Unilabs is one of Europe’s largest diagnostics companies. It offers a complete range of laboratory, pathology and imaging services for patients all around the world. With 12,700 employees across 150 imaging centres and 250 labs in 17 countries, we perform more than four million lab tests a week – saving lives every single day.